Norepinephrine: hormone and neurotransmitter in man.

To determine whether norepinephrine could subserve a hormonal as well as a neurotransmitter function, norepinephrine was infused for 60 min into each of five normal young men in doses of 0.1, 0.5, 1.0, 2.5, and 5.0 microgram/min. After infusion, the plasma norepinephrine concentration fell with a mean (+/-SD) half-time of 2.4 +/- 0.7 min. The mean (+/-SD) norepinephrine metabolic clearance rate was 3,070 +/- 200 ml/min. The calculated basal plasma norepinephrine production rate was 0.7 microgram/min. The blood pressure and circulating glycerol, acetoacetate, beta-hydroxybutyrate, and glucose (increased) and the heart rate and circulating insulin, lactate, pyruvate, and alanine (decreased) exhibited highly significant parabolic relationships with the steady-state plasma norepinephrine concentrations. However, norepinephrine levels in excess of 1,800 pg/ml were required to produce hemodynamic and/or metabolic effects. Thus, under usual conditions, the biologic actions of norepinephrine can be attributed only to its sympathetic neurotransmitter function. Plasma norepinephrine concentrations do at times exceed 1,800 pg/ml during exercise and during major acute illness. Thus, under conditions of stress, norepinephrine may subserve a hormonal, as well as a neurotransmitter, function.

[1]  N. Christensen,et al.  Plasma catecholamines and carbohydrate metabolism in patients with acute myocardial infarction. , 1974, The Journal of clinical investigation.

[2]  N. Christensen.  Plasma Norepinephrine and Epinephrine in Untreated Diabetics, During Fasting and After Insulin Administration , 1974, Diabetes.

[3]  P. Cryer.  Pheochromocytoma and autonomic dysfunction. , 1977, Archives of internal medicine.

[4]  O. H. Lowry,et al.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN. , 1964, The Journal of biological chemistry.

[5]  G. Powis.  The binding of catecholamines to human serum proteins. , 1975, Biochemical pharmacology.

[6]  D. Kipnis,et al.  A microfluorometric enzymatic assay for the determination of alanine and pyruvate in plasma and tissues. , 1972, The Journal of laboratory and clinical medicine.

[7]  G. Cohen,et al.  PLASMA CONCENTRATIONS OF EPINEPHRINE AND NOREPINEPHRINE DURING INTRAVENOUS INFUSIONS IN MAN , 1959, The Journal of clinical investigation.

[8]  D. Greene,et al.  The hemodynamic response of man to nor-epinephrine and epinephrine and its relation to the problem of hypertension. , 1948, The American journal of medicine.

[9]  C. Migeon,et al.  Comparison of competitive protein binding radioassay of cortisol to double isotope dilution and Porter Silber methods. , 1970, Steroids.

[10]  D. Schalch,et al.  A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma , 1964, Nature.

[11]  J. Peuler,et al.  A simplified radiometric assay for plasma norepinephrine and epinephrine. , 1973, Analytical biochemistry.

[12]  P. Cryer.  Isotope-derivative Measurements of Plasma Norepinephrine and Epinephrine in Man , 1976, Diabetes.

[13]  J. Watson,et al.  Enzymic assay of glycerol, dihydroxyacetone, and glyceraldehyde. , 1967, Archives of biochemistry and biophysics.

[14]  A. Lazarow,et al.  Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats , 1963, Diabetes.

[15]  L. Heding,et al.  The influence of short term submaximal work on the plasma concentrations of catecholamines, pancreatic glucagon and growth hormone in man. , 1975, Acta endocrinologica.

[16]  W. Louis,et al.  Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression. , 1975, Clinical science and molecular medicine. Supplement.

[17]  A. Anton,et al.  Distribution of metanephrine and normetanephrine in various animals and their analysis in diverse biologic material. , 1966, The Journal of pharmacology and experimental therapeutics.

[18]  D. Kipnis,et al.  Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma. , 1975, The American journal of medicine.

[19]  D. Kipnis,et al.  Alanine and glutamine synthesis and release from skeletal muscle. IV. beta-Adrenergic inhibition of amino acid release. , 1976, The Journal of biological chemistry.

[20]  N. Christensen,et al.  Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. , 1975, Journal of applied physiology.

[21]  J. Exton,et al.  Studies on the alpha-adrenergic activation of hepatic glucose output. I. Studies on the alpha-adrenergic activation of phosphorylase and gluconeogenesis and inactivation of glycogen synthase in isolated rat liver parenchymal cells. , 1976, The Journal of biological chemistry.

[22]  P. Cryer,et al.  The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. , 1976, The Journal of clinical investigation.

[23]  P. Cryer,et al.  Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture. , 1974, The Journal of clinical endocrinology and metabolism.

[24]  P. Cryer,et al.  Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. , 1976, The New England journal of medicine.

[25]  D. Kipnis,et al.  Hormone-fuel interrelationships during fasting. , 1966, The Journal of clinical investigation.

[26]  R. Sherwin,et al.  Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon. , 1976, The Journal of clinical investigation.

[27]  J. Maas,et al.  A kinetic study of the disposition of circulating norepinephrine in normal male subjects. , 1970, The Journal of pharmacology and experimental therapeutics.

[28]  W. Louis,et al.  The use of a double-isotope derivative plasma assay for noradrenaline and adrenaline in the diagnosis and localisation of phaeochromocytoma. , 1971, Australian and New Zealand journal of medicine.